Abstract
We synthesized (4R,5S)/(4S,5R)-N-propargyl-4,5-bis(2-chloro-4-methoxy/hydroxyphenyl)-2-imidazolines (1 and 2) as estrogenic carriers for the dicobalthexacarbonyl fragment. The OH-substituted ligand 2 and its related complex 2-Co(2)(CO)(6) showed estrogenic activity in a transcriptional assay in ERalpha-containing MCF-7-2a cells. The cytotoxicity against breast cancer cell lines was more pronounced for the related O-methyl derivative 1-Co(2)(CO)(6). Further pharmacological investigations were performed on the cellular uptake into MCF-7 and MDA-MB-231 cells, the ability of binding to DNA, and the inactivation by HSA.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alkynes / chemistry*
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Cobalt / chemistry*
-
DNA / metabolism
-
Dose-Response Relationship, Drug
-
Drug Screening Assays, Antitumor
-
Estrogen Receptor alpha / metabolism
-
Estrogens / chemistry*
-
Humans
-
Imidazolines / chemistry*
-
Ligands
-
Molecular Structure
-
Organometallic Compounds / chemical synthesis*
-
Organometallic Compounds / chemistry
-
Organometallic Compounds / pharmacology*
-
Stereoisomerism
-
Time Factors
Substances
-
Alkynes
-
Estrogen Receptor alpha
-
Estrogens
-
Imidazolines
-
Ligands
-
Organometallic Compounds
-
Cobalt
-
DNA